A citation-based method for searching scientific literature

Hongda Zhu, Wenya Linda Bi, Ayal Aizer, Lingyang Hua, Mi Tian, Jiaojiao Den, Hailiang Tang, Hong Chen, Yin Wang, Ying Mao, Ian F Dunn, Qing Xie, Ye Gong. Cancer Med 2019
Times Cited: 27







List of co-cited articles
143 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
51

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
390
44

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
Leland Rogers, Peixin Zhang, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, David Brachman, Joseph M Jenrette,[...]. J Neurosurg 2018
117
33

WHO grade II and III meningiomas: a study of prognostic factors.
Anne Durand, François Labrousse, Anne Jouvet, Luc Bauchet, Michel Kalamaridès, Philippe Menei, Robert Deruty, Jean Jacques Moreau, Michelle Fèvre-Montange, Jacques Guyotat. J Neurooncol 2009
204
33

Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: A phase-II parallel non-randomized and observation study (EORTC 22042-26042).
Damien C Weber, Carmen Ares, Salvador Villa, Saskia M Peerdeman, Laurette Renard, Brigitta G Baumert, Anna Lucas, Theo Veninga, Alessia Pica, Sarah Jefferies,[...]. Radiother Oncol 2018
71
33

Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Chenyang Wang, Tania B Kaprealian, John H Suh, Charlotte D Kubicky, Jeremy N Ciporen, Yiyi Chen, Jerry J Jaboin. Neuro Oncol 2017
59
29

Adjuvant radiotherapy for atypical meningiomas.
Hilary P Bagshaw, Lindsay M Burt, Randy L Jensen, Gita Suneja, Cheryl A Palmer, William T Couldwell, Dennis C Shrieve. J Neurosurg 2017
59
29

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
Ayal A Aizer, Nils D Arvold, Paul Catalano, Elizabeth B Claus, Alexandra J Golby, Mark D Johnson, Ossama Al-Mefty, Patrick Y Wen, David A Reardon, Eudocia Q Lee,[...]. Neuro Oncol 2014
62
25


Radiotherapy for atypical meningiomas.
Richard Mair, Kevin Morris, Ian Scott, Thomas A Carroll. J Neurosurg 2011
123
25

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation.
Manish K Aghi, Bob S Carter, Garth R Cosgrove, Robert G Ojemann, Sepideh Amin-Hanjani, Robert L Martuza, William T Curry, Fred G Barker. Neurosurgery 2009
308
25

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.
Michael D Jenkinson, Mohsen Javadpour, Brian J Haylock, Bridget Young, Helen Gillard, Jacqui Vinten, Helen Bulbeck, Kumar Das, Michael Farrell, Seamus Looby,[...]. Trials 2015
110
25

Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Saman Moritz Hemmati, Pirus Ghadjar, Arne Grün, Harun Badakhshi, Sebastian Zschaeck, Carolin Senger, Güliz Acker, Martin Misch, Volker Budach, David Kaul. Radiat Oncol 2019
19
36

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
S-Y Yang, C-K Park, S-H Park, D G Kim, Y S Chung, H-W Jung. J Neurol Neurosurg Psychiatry 2008
187
22

Early adjuvant radiotherapy in the treatment of atypical meningioma.
Michael D Jenkinson, Mueez Waqar, Jibril Osman Farah, Michael Farrell, Giuseppe M V Barbagallo, Robin McManus, Seamus Looby, Deirdre Hussey, David Fitzpatrick, Francesco Certo,[...]. J Clin Neurosci 2016
49
22

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Gurvinder Kaur, Eli T Sayegh, Andrew Larson, Orin Bloch, Michelle Madden, Matthew Z Sun, Igor J Barani, C David James, Andrew T Parsa. Neuro Oncol 2014
128
22

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
341
22

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015.
Quinn T Ostrom, Haley Gittleman, Gabrielle Truitt, Alexander Boscia, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2018
22

Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
Waseem Masalha, Dieter Henrik Heiland, Pamela Franco, Daniel Delev, Jan Gerrit Haaker, Oliver Schnell, Christian Scheiwe, Juergen Grauvogel. J Neurooncol 2018
34
22

Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment.
Salah Hammouche, Simon Clark, Alex Hie Lin Wong, Paul Eldridge, Jibril Osman Farah. Acta Neurochir (Wien) 2014
94
18

Long-Term Outcomes of Newly Diagnosed Resected Atypical Meningiomas and the Role of Adjuvant Radiotherapy.
Ming Zhi, Michael R Girvigian, Michael J Miller, Joseph C Chen, Andrew J Schumacher, Javad Rahimian, Kenneth Lodin. World Neurosurg 2019
27
18

An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sam Q Sun, Ammar H Hawasli, Jiayi Huang, Michael R Chicoine, Albert H Kim. Neurosurg Focus 2015
82
18

Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Christopher S Graffeo, Heather E Leeper, Avital Perry, Joon H Uhm, Daniel J Lachance, Paul D Brown, Daniel J Ma, Jamie J Van Gompel, Caterina Giannini, Derek R Johnson,[...]. World Neurosurg 2017
37
18

Skull base atypical meningioma: long term surgical outcome and prognostic factors.
Yu-Chi Wang, Chi-Cheng Chuang, Kuo-Chen Wei, Yung-Hsin Hsu, Peng-Wei Hsu, Shih-Tseng Lee, Chieh-Tsai Wu, Chen-Kan Tseng, Chun-Chieh Wang, Yao-Liang Chen,[...]. Clin Neurol Neurosurg 2015
33
14

TERT Promoter Mutations and Risk of Recurrence in Meningioma.
Felix Sahm, Daniel Schrimpf, Adriana Olar, Christian Koelsche, David Reuss, Juliane Bissel, Annekathrin Kratz, David Capper, Sebastian Schefzyk, Thomas Hielscher,[...]. J Natl Cancer Inst 2015
194
14

Genomic landscape of high-grade meningiomas.
Wenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, Jeremiah Wala, Will J Gibson, Pankaj K Agarwalla, Peleg Horowitz, Steven E Schumacher, Ekaterina Esaulova, Yu Mei,[...]. NPJ Genom Med 2017
87
14

Prognostic factors for progression in atypical meningioma.
Shakir I Shakir, Luis Souhami, Kevin Petrecca, Jose João Mansure, Khushdeep Singh, Valerie Panet-Raymond, George Shenouda, Amal A Al-Odaini, Bassam Abdulkarim, Marie-Christine Guiot. J Neurosurg 2018
33
14


Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
311
14

Survival and Prognostic Predictors of Anaplastic Meningiomas.
Waseem Masalha, Dieter Henrik Heiland, Daniel Delev, Jamina Tara Fennell, Pamela Franco, Christian Scheiwe, Bianca-Ioana Mercas, Irina Mader, Oliver Schnell, Juergen Grauvogel. World Neurosurg 2019
10
40

Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.
Muhammad O Chohan, Christopher T Ryan, Ranjodh Singh, Ryan M Lanning, Anne S Reiner, Marc K Rosenblum, Viviane Tabar, Philip H Gutin. Neurosurgery 2018
15
26

High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539.
C Leland Rogers, Minhee Won, Michael A Vogelbaum, Arie Perry, Lynn S Ashby, Jignesh M Modi, Anthony M Alleman, James Galvin, Shannon E Fogh, Emad Youssef,[...]. Int J Radiat Oncol Biol Phys 2020
48
14

Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Nicholas R Rydzewski, Maciej S Lesniak, James P Chandler, John A Kalapurakal, Erqi Pollom, Matthew C Tate, Orin Bloch, Timothy Kruser, Prarthana Dalal, Sean Sachdev. Cancer 2018
39
14

Risk factors associated with postoperative recurrence in atypical intracranial meningioma: analysis of 263 cases at a single neurosurgical centre.
Fang Wang, Dingkang Xu, Yumeilan Liu, Yazhou Lin, Qingjie Wei, Qiang Gao, Shixiong Lei, Fuyou Guo. Acta Neurochir (Wien) 2019
15
26

Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
Ammoren Dohm, Emory R McTyre, Michael D Chan, Claire Fan, Scott Isom, J Daniel Bourland, Ryan T Mott, Christina K Cramer, Stephen B Tatter, Adrian W Laxton. J Clin Neurosci 2017
20
20

Treatment Protocol, Long-Term Follow-Up, and Predictors of Mortality in 302 Cases of Atypical Meningioma.
Huan Li, Yun-Sheng Zhang, Guo-Bin Zhang, Gui-Jun Zhang, Bo Wang, Da Li, Zhen Wu, Jun-Ting Zhang. World Neurosurg 2019
14
28

The role of adjuvant radiotherapy after gross total resection of atypical meningiomas.
Shaakir Hasan, Michael Young, Trevine Albert, Ashish H Shah, Christian Okoye, Amade Bregy, Simon S Lo, Fazilat Ishkanian, Ricardo J Komotar. World Neurosurg 2015
53
14

The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
Douglas A Hardesty, Andrew B Wolf, David G Brachman, Heyoung L McBride, Emad Youssef, Peter Nakaji, Randall W Porter, Kris A Smith, Robert F Spetzler, Nader Sanai. J Neurosurg 2013
105
14

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Quinn T Ostrom, Nirav Patil, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2020
498
14

Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Sebastian Adeberg, Christian Hartmann, Thomas Welzel, Stefan Rieken, Daniel Habermehl, Andreas von Deimling, Jürgen Debus, Stephanie E Combs. Int J Radiat Oncol Biol Phys 2012
101
14

Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
David P Bray, Joseph W Quillin, Robert H Press, Yilin Yang, Zhengjia Chen, Bree R Eaton, Jeffrey J Olson. Neurosurgery 2021
7
57

Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
Victoria E Clark, Akdes Serin Harmancı, Hanwen Bai, Mark W Youngblood, Tong Ihn Lee, Jacob F Baranoski, A Gulhan Ercan-Sencicek, Brian J Abraham, Abraham S Weintraub, Denes Hnisz,[...]. Nat Genet 2016
176
14


Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
Alexander M Stessin, Allie Schwartz, Grigorij Judanin, Susan C Pannullo, John A Boockvar, Theodore H Schwartz, Philip E Stieg, A Gabriella Wernicke. J Neurosurg 2012
74
11

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Thomas J Kaley, Patrick Wen, David Schiff, Keith Ligon, Sam Haidar, Sasan Karimi, Andrew B Lassman, Craig P Nolan, Lisa M DeAngelis, Igor Gavrilovic,[...]. Neuro Oncol 2015
143
11

Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents?
Constantin A Dasanu, Yazeed Samara, Ion Codreanu, Farhad M Limonadi, Omid Hamid, Juliana Alvarez-Argote. J Oncol Pharm Pract 2019
10
30

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
Kent C Shih, Sajeel Chowdhary, Paul Rosenblatt, Alva B Weir, Gregg C Shepard, Jeffrey T Williams, Mythili Shastry, Howard A Burris, John D Hainsworth. J Neurooncol 2016
52
11

Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Lingyang Hua, Hongda Zhu, Jingrun Li, Hailiang Tang, Dapeng Kuang, Yin Wang, Feng Tang, Xiancheng Chen, Liangfu Zhou, Qing Xie,[...]. J Neurosurg 2018
19
15

Long-term 25-year follow-up of surgically treated parasagittal meningiomas.
Jenny Pettersson-Segerlind, Abiel Orrego, Stefan Lönn, Tiit Mathiesen. World Neurosurg 2011
72
11

Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma.
Christos Boskos, Loic Feuvret, Georges Noel, Jean-Louis Habrand, Pascal Pommier, Claire Alapetite, Hamid Mammar, Regis Ferrand, Gilbert Boisserie, Jean-Jacques Mazeron. Int J Radiat Oncol Biol Phys 2009
96
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.